IndietroControlling Microbial Growth in the Body: Antimicrobial Drugs – Study Notes
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Controlling Microbial Growth in the Body: Antimicrobial Drugs
Definitions of Key Terms
Antimicrobial agents: Chemical substances used to kill or inhibit the growth of microorganisms, including bacteria, fungi, viruses, and protozoa.
Antibiotics: Antimicrobial agents produced naturally by microorganisms (such as bacteria or fungi) that inhibit or kill other microbes.
Semisynthetic antimicrobials: Chemically modified derivatives of natural antibiotics designed to improve efficacy, stability, or spectrum of activity.
Synthetic drugs: Antimicrobial compounds synthesized entirely in the laboratory, not derived from natural sources.
Clinical Considerations in Prescribing Antimicrobial Drugs
When selecting an antimicrobial drug, clinicians must consider the drug's spectrum of activity, effectiveness, route of administration, and potential side effects.
Narrow-Spectrum vs. Broad-Spectrum Drugs
Narrow-spectrum drugs: Effective against a limited range of microorganisms (e.g., only Gram-positive bacteria). Example: Penicillin G.
Broad-spectrum drugs: Effective against a wide variety of microorganisms, including both Gram-positive and Gram-negative bacteria. Example: Tetracycline.
Pros of narrow-spectrum: Less disruption of normal microbiota, reduced risk of secondary infections.
Cons of narrow-spectrum: May not be effective if the causative agent is unknown.
Pros of broad-spectrum: Useful for treating mixed infections or when the pathogen is unidentified.
Cons of broad-spectrum: Increased risk of superinfections and disruption of normal microbiota.
Tests for Effectiveness of Antimicrobial Drugs
Several laboratory tests are used to determine the susceptibility of microorganisms to antimicrobial agents:
Diffusion susceptibility test (Kirby-Bauer test): Disks impregnated with antimicrobial agents are placed on an agar plate inoculated with the test organism. Zones of inhibition around the disks indicate susceptibility.
Minimum inhibitory concentration (MIC): The lowest concentration of a drug that inhibits visible growth of a microorganism. Determined by serial dilution methods.
Etest: A plastic strip with a gradient of antibiotic concentration is placed on an inoculated agar plate. The MIC is read where the zone of inhibition intersects the strip.
Minimum bactericidal concentration (MBC) test: Determines the lowest concentration of an antimicrobial that kills 99.9% of the original inoculum. Involves subculturing from MIC tubes onto drug-free media.
Routes of Administration
Topical (local): Applied directly to the site of infection; suitable for external infections.
Oral: Taken by mouth; convenient but may result in lower and less predictable drug concentrations.
Intramuscular (IM): Injected into muscle; allows for moderate absorption and sustained drug levels.
Intravenous (IV): Delivered directly into the bloodstream; provides rapid and high drug concentrations.
Considerations: Effective concentration at the site of infection, diffusion rate, drug clearance rate, and patient compliance (especially for oral drugs). Co-administration of certain nonantimicrobial drugs can prolong the antimicrobial's activity.
Safety and Side Effects
Antimicrobial therapy can cause adverse effects, which must be considered when prescribing drugs:
Toxicity: Some drugs can damage host tissues or organs (e.g., nephrotoxicity, ototoxicity).
Allergic reactions: Hypersensitivity responses can range from mild rashes to life-threatening anaphylaxis.
Disruption of normal microbiota: Broad-spectrum drugs may eliminate beneficial microbes, leading to superinfections (e.g., Clostridioides difficile colitis).
Resistance to Antimicrobial Drugs
Microorganisms can develop resistance to antimicrobial agents through various mechanisms:
Enzymatic destruction or inactivation of the drug (e.g., beta-lactamases hydrolyzing penicillins).
Alteration of drug targets (e.g., changes in ribosomal proteins preventing antibiotic binding).
Decreased permeability or increased efflux of the drug from the cell.
Bypass of the metabolic pathway inhibited by the drug.
Selected Antimicrobials: Mechanisms and Spectrum
For each of the following drugs, know the mechanism of action and the types of organisms targeted.
Drug/Class | Mechanism of Action | Effective Against | Example/Notes |
|---|---|---|---|
Penicillin | Inhibits cell wall synthesis by blocking transpeptidation of peptidoglycan | Mainly Gram-positive bacteria | Penicillin G is a classic example; resistance common due to beta-lactamases |
Bacitracin | Inhibits cell wall synthesis by interfering with peptidoglycan precursor transport | Gram-positive bacteria | Commonly used topically due to toxicity if ingested |
Tetracycline | Inhibits protein synthesis by binding to the 30S ribosomal subunit | Broad-spectrum: Gram-positive and Gram-negative bacteria, some intracellular pathogens | Can cause discoloration of teeth in children |
Polymyxin | Disrupts cytoplasmic membranes by interacting with phospholipids | Gram-negative bacteria | Used topically due to nephrotoxicity |
Sulfonamide | Inhibits folic acid synthesis by competing with para-aminobenzoic acid (PABA) | Broad-spectrum: Gram-positive and Gram-negative bacteria | Often used in combination with trimethoprim |
Actinomycin | Inhibits RNA synthesis by binding to DNA | Primarily used as an anticancer agent; limited antibacterial use | Toxic to eukaryotic cells as well |
Streptomycin | Inhibits protein synthesis by binding to the 30S ribosomal subunit, causing misreading of mRNA | Broad-spectrum; effective against Mycobacterium tuberculosis | Aminoglycoside; can cause ototoxicity |
Quinolones | Inhibit DNA gyrase (topoisomerase II), blocking DNA replication | Broad-spectrum: Gram-positive and Gram-negative bacteria | Ciprofloxacin is a common example |
Example: Streptomycin is used in combination therapy for tuberculosis due to its effectiveness against Mycobacterium tuberculosis, but its use is limited by potential side effects such as hearing loss.
Additional info: Mechanisms of resistance and clinical considerations are critical for effective antimicrobial therapy and for minimizing the development of drug-resistant pathogens.